Sientra enters into services agreement with Vesta regarding breast implants

Sientra announced it has entered into a services agreement with Vesta for manufacturing of breast implants, according to a press release.

Vesta will establish manufacturing capacity for Sientra, a medical aesthetics company, and is working to finalize a long-term supply agreement for Sientra’s PMA-approved breast implants, according to the release from Seintra.

Sientra reports it anticipants submitting a PMA Supplement to the FDA in the first quarter of 2107.

“Our relationship with Vesta is an important component of our comprehensive manufacturing plan,” Jeffrey M. Nugent, chairman and CEO of Sientra, stated in the release. “Vesta is an established manufacturer with proven capabilities in producing implantable silicone medical devices and components with a strong reputation for quality and safety. We have already made significant progress with Vesta and we are confident that this ongoing relationship will enable us to uphold our promise to board-certified plastic surgeons to maintain an uninterrupted supply of our breast implant products.”

Vesta, a medical devices contract manufacturer of silicone products and other medical devices, is a Lubrizol LifeSciences company.

“Our experience in the implantable cosmetic market and our know-how of silicone component manufacturing positions us well to best support Sientra’s continued success,” Deb Langer, vice president and general manager of Lubrizol LifeSciences, stated in the release.

Reference: www.sientra.com